Table 1 Use of antihypertensive medicines by class (defined daily dose [DDD] and proportion [%]) for single and combination products in Ghana and Nigeria
From: Antihypertensive medicine use differs between Ghana and Nigeria
| Â | Ghana | Nigeria | ||
|---|---|---|---|---|
Use (DDD) | % | Use (DDD) | % | |
Single | Â | Â | Â | Â |
ARB | 380,029 | 39.2 | 940,546 | 26.7 |
CCB | 310,645 | 32.1 | 803,845 | 22.8 |
ACEi | 129,783 | 13.4 | 514,422 | 14.6 |
DU | 72,272 | 7.5 | 651,408 | 18.5 |
BB | 65,393 | 6.7 | 211,322 | 6.0 |
AAC | 4,528 | 0.5 | 107,321 | 3.0 |
AAP | – | 0 | 23,466 | 0.7 |
Total | 962,650 | 99.4 | 3,252,329 | 92.3 |
Combination | Â | Â | Â | Â |
DU + DU |  | 0 | 218,619 | 6.2 |
BB + DU | 342 | 0.0 | 10,421 | 0.3 |
CCB + ARB |  | 0 | 12,360 | 0.4 |
CCB + ARB + DU |  | 0 | 27,665 | 1.3 |
CCB + ST | 5813 | 0.6 | 1290 | 0.0 |
ACEi + ARB |  |  | 2 | 0.0 |
Total | 6155 | 0.6 | 270,357 | 7.7 |